• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA LIFESCIENCES CORP. BILAYER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA LIFESCIENCES CORP. BILAYER Back to Search Results
Lot Number 105A00165834
Device Problem Failure To Adhere Or Bond (1031)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Ulcer (2274); Pressure Sores (2326)
Event Date 04/27/2010
Event Type  Injury  
Event Description
It was reported as part of a study conducted titled: "a retrospective, multi-center study evaluating the outcomes for integra skin sheet bilayer or single layer products used in complex lower extremity soft tissue reconstruction." this is the second report of two reports concerning the same pt.See mfg report no: 1121308-2014-00017.The pt received integra bilayer implanted on (b)(6) 2010 to a wound, which was on the right plantar foot, had an etiology listed as ischemic diabetic neuropathic-ulcer, pressure ulcer.The wound's approximate measurement was 4cm length x 5cm width.After the initial index surgery with integra bilayer, the pt was readmitted on (b)(6), 2010 for negative pressure wound therapy (npwt) and a split thickness skin graft (stsg).On (b)(6)2010, the pt experienced a serious adverse event of "dehiscence." this event was documented as severe, possibly related to the initial index treatment with integra, and deemed ongoing at the time of 1 year f/u.The action taken was receipt of concomitant medications/therapy (not specified) and readmission and reoperation.The pt was readmitted (b)(6), 2010 for npwt and a stsg and then again on (b)(6), 2011 for a local flap.This pt experienced a second adverse event on (b)(6) 2010 of "infection." this event was documented as moderate in severity, possibly related to the initial index treatment with integra, and considered not a serious event.The action taken was receipt of concomitant medications/therapy (oral antibiotics not specified).The event was deemed resolved (b)(6) 2010.
 
Manufacturer Narrative
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based upon the reported info.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BILAYER
Type of Device
BILAYER
Manufacturer (Section D)
INTEGRA LIFESCIENCES CORP.
plainsboro NJ 08536
Manufacturer Contact
caren finfelstein
315 enterprise dr
plainsboro, NJ 08536
6099362341
MDR Report Key3879367
MDR Text Key4568405
Report Number1121308-2014-00018
Device Sequence Number1
Product Code FRO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K021792
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 05/09/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2011
Device Lot Number105A00165834
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/09/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-